Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04409106
Other study ID # 2020/5
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 10, 2020
Est. completion date February 10, 2021

Study information

Verified date February 2021
Source Istanbul University-Cerrahpasa
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Parental Smartphone Use Management Scale (PSUMS) was originally developed in English language to parents to educate adolescents and communicate with them about online behavior and safety, as well as to conduct plans to manage adolescents' internet and smartphone use. The purpose of this study was to translate and cross-culturally adapt the PSUMS.


Description:

Parental Smartphone Use Management Scale (PSUMS) was originally developed in English language to parents to educate adolescents and communicate with them about online behavior and safety, as well as to conduct plans to manage adolescents' internet and smartphone use. The purpose of this study was to translate and cross-culturally adapt the PSUMS. The study will include adults who have been using smartphones for at least the past month and have children aged 11-18. For cross-cultural adaptation, two bi-lingual translators used the back-translation procedure. Within a 5-to-7 day period after first assessment, the participants completed the Turkish version of the Parental Smartphone Use Management Scale (PSUMS) to evaluate test-retest reliability. Cronbach's alpha (α) was used to assess internal consistency. The correlations with the Turkish version of The Smart Phone Addiction Scale-Short Form for Adolescent and the Turkish version of PedsQL in Adolescents 13-18 years old will determine to check the validity.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date February 10, 2021
Est. primary completion date October 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Working at Istanbul University-Cerrahpasa Faculty of Health Sciences - Having children using smart phones for at least the last one month - Having children between aged 11 and 18 years. - Being a volunteer to participate Exclusion Criteria: - Having any serious vision problems or cognitive impairment - Having disabilities in understanding, speaking and reading Turkish

Study Design


Locations

Country Name City State
Turkey Istanbul University- Cerrahpasa Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University-Cerrahpasa

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Hsieh YP, Yen CF, Chou WJ. Development and Validation of the Parental Smartphone Use Management Scale (PSUMS): Parents' Perceived Self-Efficacy with Adolescents with Attention Deficit Hyperactivity Disorder. Int J Environ Res Public Health. 2019 Apr 21;16 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Parental Smartphone Use Management Scale (PSUMS) Prior to developing the PSUMS, an item pool was established by conducting a literature review and a focus group. The item pool contained 18 items. A 7-point Likert scale was used to rate the level of agreement with items, ranging from 0 (no efficacy at all) to 6 (very strong efficacy). Baseline (First assessment)
Secondary Parental Smartphone Use Management Scale (PSUMS) Prior to developing the PSUMS, an item pool was established by conducting a literature review and a focus group. The item pool contained 18 items. A 7-point Likert scale was used to rate the level of agreement with items, ranging from 0 (no efficacy at all) to 6 (very strong efficacy). Within a 5-to-7-day period after the first assessment (Second assessment)
Secondary Smartphone Addiction Scale -Short form for adolescent Version (SAS-SF) Smartphone Addiction Scale -Short form for adolescent Version (SAS-SF) is a self-report scale with 10 items rated on a 6-point Likert scale (1= largely untrue, 6= largely true). Higher scores from the scale indicate higher level of the smartphone addiction. . The validity and reliability study of the questionnaire was done in Turkish. Baseline (First assessment)
Secondary PedsQL in Adolescents It is a general quality of life scale that evaluates the physical and psychosocial lives of children between the ages of 11-18. The scale prepared for the 13-18 age group has a parent and child form. The parent form is filled out by the caregiver and the adolescent form by the child included in the study separately and simultaneously. The most important features are that "PedsQL in adolescents" is short, it can be filled in about 5-10 minutes, and it is easy to apply and score by the researcher. Baseline (First assessment)
See also
  Status Clinical Trial Phase
Terminated NCT03576768 - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt N/A
Completed NCT04110626 - Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
Completed NCT03007940 - Using NIATx Strategies to Implement Integrated Services in Routine Care N/A
Not yet recruiting NCT04030858 - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery N/A
Completed NCT03347643 - The Effectiveness of tDCS on Internet Game Addiction Phase 2
Active, not recruiting NCT02836080 - Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT) N/A
Completed NCT03221985 - ESM Pilot: Mobile Phones and Psychology N/A
Completed NCT02556060 - Lamotrigine for Ketamine Dependence Trial Phase 2/Phase 3
Completed NCT02812810 - Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence N/A
Completed NCT01531153 - Cognitive Enhancement as a Target for Cocaine Pharmacotherapy N/A
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Not yet recruiting NCT06459609 - Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment N/A
Recruiting NCT05595759 - Violence Against Women in Patients With Alcohol Substance Addiction Training N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Recruiting NCT04959643 - Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
Completed NCT04133688 - Mobile App in Addiction N/A
Recruiting NCT04063267 - Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder Phase 2
Completed NCT05114577 - Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery N/A
Terminated NCT02671240 - Prognosis of Behavioral Addiction in Parkinson's Disease
Not yet recruiting NCT03813095 - Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction Phase 2